CHR Share Price Performance
Recent CHR News & Updates
No updates
Chr. Hansen Holding A/S Key Details
Last Reported Earnings
Aug 31, 2023
Next Reporting Earnings
Apr 04, 2024
- Earnings per share (EPS)
- 1.72
- Gross Margin
- 54.20%
- Net Profit Margin
- 17.01%
- Debt/Equity Ratio
- 52.0%
Chr. Hansen Holding A/S Competitors
About CHR
- Founded
- 1843
- Employees
- 3834
- CEO
- WebsiteView website
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry. The Health & Nutrition segment produces and sells products for the dietary supplement, over-the-counter pharmaceutical, infant formula, animal feed, and plant protection industries. It has a strategic collaboration with UPL Ltd. to develop and commercialize microbial-based bio solutions for sustainable agriculture. The company was founded in 1843 and is headquartered in Hørsholm, Denmark. As of January 29, 2024, Chr. Hansen Holding A/S operates as a subsidiary of Novozymes A/S.
Danish Market Performance
- 7 Days: 5.1%
- 3 Months: 10.8%
- 1 Year: -29.1%
- Year to Date: -14.2%
The market has climbed 5.1% in the last 7 days, lead by the Healthcare sector with a gain of 7.9%. Over the past year the market is down 29%. As for the next few years, earnings are expected to grow by 7.7% per annum. Market details ›
Companies across the globe are beginning to pay attention to agentic AI. It’s also a term you’re likely to hear a lot during earnings season. In fact, it came up 26 times during...
Continue reading